yOUR dRUG EFFICACY. 
NOW REVEALED.

Biomarkers-Youtube-synapcell

who we are

Grenoble, France, is often referred to as the French Silicon Valley. This place has seen a bunch of innovations coming to life from its top-level labs in the field of Medical Technologies, Diagnostics, Nanotechnologies, Artificial Intelligence, Life Sciences and Neuroscience. 

This is where we created SynapCell in 2005.  We strive to deliver excellent science, always questionning our findings to innovate and advance our understanding of brain function.

Studying brain electrical activity is what makes our approach unique, unlocking the true potential of your drug candidates at the preclinical step.

our purpose: PUSH THE BOUNDARImS OF NEUROSCIENCE

  • Patients with Brain diseases have no curative therapeutic treatment yet available to improve their lives.
  • Most drug failures occur too late in the development process (Phase II), most of the time because drug candidates aren’t effective enough to get a green light.

Our translational efficacy assays quantify your drug effect inside the brain with the help of disease-specific & objective biomarkers.

It becomes now possible to predict your compound’s in-human efficacy as early as at the preclinical step with clinically-relevant models of Epilepsy, Parkinson’s disease, or cognitive impairment, avoiding further time-consuming and costly trials.

+ 0
years-old company
0
Collaborators
0
liters of coffee drunk/indiv/year

Study Design

Proud to propose non-off-the-shelf partnerships with you. Because each of your projects is unique, every successful collaboration starts with a one-to-one discussion. Together, we exchange about your needs, time and resource constraints to build and fine-tune the best study design for you.

We decided not to propose endless service listings but rather focused, precise and fully-controlled testing capabilities for Epilepsy, Parkinson’s Disease and Cognitive function.

oUTSIDE THE BOX

We therefore have a R&D activity, consisting in innovating to discover new translational EEG biomarkers for brain diseases, a CRO activity for compound testing at the preclinical step, and an Open innovation activity that offers sponsorhip and long-term partnering with you.

Let's talk about your next project